Featured Research

from universities, journals, and other organizations

Abortion Pill Compound Prevents Breast Tumor Growth

Date:
December 1, 2006
Source:
University of California - Irvine
Summary:
The chemical compound for the abortion pill has been found to prevent the growth of mammary tumors caused by the mutant gene responsible for a majority of breast and ovarian cancers, according to UC Irvine scientists.

The chemical compound for the abortion pill has been found to prevent the growth of mammary tumors caused by the mutant gene responsible for a majority of breast and ovarian cancers, according to UC Irvine scientists.

This compound, called mifepristone, prevented breast tumors by inhibiting progesterone, a hormone involved with the female reproductive cycle, in breast tissue cells. The discovery points to new prevention methods for women who have a genetic predisposition to breast and ovarian cancers. Currently, these women often have their breasts or ovaries surgically removed to reduce the risk of developing cancer.

The study appears in the Dec. 1 issue of Science.

"We found that progesterone plays a role in the development of breast cancer by encouraging the proliferation of mammary cells that carry a breast cancer gene," said Eva Lee, lead author of the study and professor of developmental and cell biology and biological chemistry at UCI. "Mifepristone can block that response. We're excited about this discovery and hope it leads to new options for women with a high risk for developing breast cancer."

In the study, Lee and her colleagues addressed how mifepristone affects the function of mutated BRCA-1 genes in tissue. BRCA-1 is widely studied by cancer geneticists because a mutated version of this gene significantly raises the possibility of breast and ovarian cancers. By age 70, more than 50 percent of women with the mutated BRCA-1 gene develop breast or ovarian cancer.

The researchers studied mice that carried the mutated BRCA-1 gene. Mice treated with mifepristone, an anti-progesterone compound, did not develop mammary tumors by the time they reached one year of age. All of the untreated mice, however, developed tumors by eight months of age.

Progesterone, secreted by the ovaries, is essential to the maintenance of a pregnancy. Mifepristone, also called RU486, is designed to abort pregnancy in the first trimester by blocking progesterone, thereby ending the viability of the fetus. In smaller doses, it is used as an emergency contraceptive.

UCI researchers found that progesterone encourages the development of cancer when the mutated BRCA-1 is present because it speeds up the division of cells. Mifepristone was found to block a binding process that is necessary for progesterone to cause the cell division.

Previous studies conducted by other researchers linked high progesterone levels with an increase in breast cancer risk, particularly in menopausal women who underwent hormone-replacement therapy that included progesterone and estrogen to ease symptoms such as hot flashes and night sweats. That research, combined with the recent findings, lead scientists to believe that anti-progesterone could, in the future, provide women at risk for breast cancer with more prevention options.

This research was supported by the National Cancer Institute, the Breast Cancer Research Foundation and the Department of Defense.


Story Source:

The above story is based on materials provided by University of California - Irvine. Note: Materials may be edited for content and length.


Cite This Page:

University of California - Irvine. "Abortion Pill Compound Prevents Breast Tumor Growth." ScienceDaily. ScienceDaily, 1 December 2006. <www.sciencedaily.com/releases/2006/11/061130191559.htm>.
University of California - Irvine. (2006, December 1). Abortion Pill Compound Prevents Breast Tumor Growth. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2006/11/061130191559.htm
University of California - Irvine. "Abortion Pill Compound Prevents Breast Tumor Growth." ScienceDaily. www.sciencedaily.com/releases/2006/11/061130191559.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins